======= PLAUR =======
== Gene Information ==
* **Official Symbol**: PLAUR
* **Official Name**: plasminogen activator, urokinase receptor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5329|5329]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q03405|Q03405]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PLAUR&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLAUR|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/173391|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. It binds both the proprotein and mature forms of urokinase plasminogen activator and permits the activation of the receptor-bound pro-enzyme by plasmin. The protein lacks transmembrane or cytoplasmic domains and may be anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety following cleavage of the nascent polypeptide near its carboxy-terminus. However, a soluble protein is also produced in some cell types. Alternative splicing results in multiple transcript variants encoding different isoforms. The proprotein experiences several post-translational cleavage reactions that have not yet been fully defined. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: N/A
|UPAR LY6|
|urokinase plasminogen activator receptor activity|
|urokinase plasminogen activator signaling pathway|
|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|
|invadopodium membrane|
|regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|
|fibrinolysis|
|positive regulation of release of cytochrome c from mitochondria|
|positive regulation of epidermal growth factor receptor signaling pathway|
|positive regulation of ERBB signaling pathway|
|regulation of release of cytochrome c from mitochondria|
|negative regulation of blood coagulation|
|negative regulation of hemostasis|
|negative regulation of coagulation|
|positive regulation of DNA binding|
|extrinsic component of membrane|
|negative regulation of wound healing|
|regulation of blood coagulation|
|regulation of hemostasis|
|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|regulation of coagulation|
|regulation of epidermal growth factor receptor signaling pathway|
|negative regulation of response to wounding|
|regulation of ERBB signaling pathway|
|negative regulation of cysteine-type endopeptidase activity|
|specific granule membrane|
|negative regulation of intrinsic apoptotic signaling pathway|
|anchored component of membrane|
|positive regulation of mitochondrion organization|
|regulation of DNA binding|
|regulation of wound healing|
|regulation of intrinsic apoptotic signaling pathway|
|regulation of response to wounding|
|positive regulation of apoptotic signaling pathway|
|positive regulation of binding|
|regulation of mitochondrion organization|
|signaling receptor activity|
|regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|negative regulation of apoptotic signaling pathway|
|regulation of cysteine-type endopeptidase activity|
|protein domain specific binding|
|negative regulation of endopeptidase activity|
|negative regulation of peptidase activity|
|blood coagulation|
|coagulation|
|hemostasis|
|endoplasmic reticulum lumen|
|signaling receptor binding|
|enzyme binding|
|negative regulation of proteolysis|
|negative regulation of response to external stimulus|
|regulation of binding|
|regulation of apoptotic signaling pathway|
|focal adhesion|
|regulation of endopeptidase activity|
|regulation of peptidase activity|
|negative regulation of hydrolase activity|
|wound healing|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|regulation of body fluid levels|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|negative regulation of intracellular signal transduction|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|chemotaxis|
|taxis|
|response to wounding|
|myeloid leukocyte activation|
|cell surface|
|positive regulation of organelle organization|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|positive regulation of cell death|
|regulated exocytosis|
|regulation of proteolysis|
|leukocyte mediated immunity|
|negative regulation of catalytic activity|
|exocytosis|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|leukocyte activation|
|endoplasmic reticulum membrane|
|negative regulation of cell death|
|secretion by cell|
|positive regulation of protein phosphorylation|
|negative regulation of cellular protein metabolic process|
|export from cell|
|positive regulation of phosphorylation|
|cell activation|
|immune effector process|
|regulation of response to external stimulus|
|negative regulation of protein metabolic process|
|secretion|
|positive regulation of phosphate metabolic process|
|positive regulation of phosphorus metabolic process|
|negative regulation of molecular function|
|negative regulation of multicellular organismal process|
|positive regulation of cellular component organization|
|positive regulation of protein modification process|
|negative regulation of signal transduction|
|regulation of hydrolase activity|
|regulation of organelle organization|
|locomotion|
|negative regulation of cell communication|
|negative regulation of signaling|
|integral component of plasma membrane|
|regulation of protein phosphorylation|
|regulation of response to stress|
|regulation of apoptotic process|
|regulation of programmed cell death|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|negative regulation of response to stimulus|
|positive regulation of signal transduction|
|regulation of cell death|
|positive regulation of protein metabolic process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
|immune response|
|extracellular region|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3157
* **Expression level (log2 read counts)**: 3.96
{{:chemogenomics:nalm6 dist.png?nolink |}}